USFDA Grants Approval To Strides Pharma For Generic GERD Treatment Formulation

Moreover, Strides Pharma’s ambitious plans to launch approximately 60 new products in the US over the next three years further underscore its commitment to portfolio diversification and expansion. This forward-looking approach aligns with the company’s overarching objective of bolstering its market presence and addressing evolving healthcare needs.
- Newsx

Related Keywords

Bengaluru ,Karnataka ,India ,Singapore ,Chennai ,Tamil Nadu , ,United States Food Drug Administration ,Strides Pharma Science ,Strides Pharma Science Limited ,Strides Pharma Global ,United States Food ,Drug Administration ,Sucralfate Oral Suspension ,Strides Pharma ,Oral Suspension ,Reference Listed Drug ,Sevelamer Carbonate Tablets ,Have You Heard About Pink ,